Radie Robert S 4

What Happened

• Robert S. Radie, a director of Rockwell Medical, was granted 9,633 restricted stock units (RSUs) on July 1, 2026. The RSUs were awarded at $0.00 (no cash paid) and are reported as an award/grant (Form 4 code A).
• The RSUs vest on July 1, 2027, subject to Radie’s continued service through the Issuer’s 2027 Annual Meeting. This is a compensation grant (not an open‑market purchase or sale).

Key Details

• Transaction date: July 1, 2026; Grant price reported: $0.00 (RSU award).
• Shares involved: 9,633 RSUs (reported post-adjustment for a 1‑for‑10 reverse split).
• Shares owned after transaction: not specified in the provided data; the Form 4 states holdings have been adjusted for the 1‑for‑10 reverse split effective July 1, 2026.
• Vesting: July 1, 2027, contingent on continued service through the 2027 Annual Meeting (see footnote).
• Filing date: Form 4 filed July 6, 2026 (investors should review the full Form 4 if timeliness is a concern).
• Transaction code: A (award/grant).

Context

• RSUs are a form of equity compensation that convert to shares only upon vesting; they are not an immediate market purchase or sale and therefore do not directly signal buying or selling intent.
• A 1‑for‑10 reverse split became effective July 1, 2026; outstanding equity awards and reported holdings were proportionately adjusted, so the reported RSU count reflects the post‑split amount.
• For full details (post‑split holdings, any tax withholding, or additional disclosures), see the complete Form 4 filing (Accession No. 0001628280-26-047121).